CC

Christina Coughlin

Chief Executive Officer

Avacta Therapeutics

Philadelphia, Pennsylvania


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Avacta Therapeutics
Industry
research
Employees
44.0
Seniority
C suite
Annual Revenue
10360000.0
Total Funding
97349200.0
Latest Funding
Other

Technologies

Outlook Gmail Google Apps Amazon AWS Wistia Google Font API Mobile Friendly Google Tag Manager WordPress.org reCAPTCHA Gravity Forms Nginx

Keywords

custom antibody alternative antibody alternatives afinnity reagents biotechnology research avacta precision affimer drug conjugates peptide drug conjugates therapeutics cancer therapies diagnostics fap targeting tumor microenvironment clinical trials oncology biosimilars biologics next-generation therapies immunotherapy targeted therapies biotherapeutics patient outcomes safety & tolerability systemic toxicity precision medicine multi-specific therapeutics antibody drug conjugates cancer treatments tumor specificity diagnostic test kits lateral flow tests biomedical products healthcare professionals immunodiagnostics biopharmaceuticals clinical proof-of-concept fibroblast activation protein platform technology therapeutic innovation phase 1 trials molecular diagnostics drug development diagnostic platforms laboratory testing market expansion healthcare partnerships shareholder value patient benefit proprietary technology health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans